DocGo Inc. Increase (Decrease) in Accounts Payable
DocGo Inc. (DCGO) reported Increase (Decrease) in Accounts Payable of $2.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-17
- DocGo Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $117.26K.
- DocGo Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.70M.
- DocGo Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $2.68M.
- DocGo Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$2.07M, a 146.59% decline year-over-year.
- DocGo Inc. increase (decrease) in accounts payable for fiscal 2025 was -$17.64M, a 312.35% decline from fiscal 2024.
- DocGo Inc. increase (decrease) in accounts payable for fiscal 2024 was $8.31M.
- DocGo Inc. increase (decrease) in accounts payable for fiscal 2023 was -$2.05M, a 156.41% decline from fiscal 2022.
- DocGo Inc. increase (decrease) in accounts payable for fiscal 2022 was $3.64M, a 69.38% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 5 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $117.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $2.82M 10-Q · filed 2026-08-17 | $5.50M derived: sum of 3 quarters · filed 2026-08-17 | $3.42M derived: sum of 4 quarters · filed 2026-08-17 | |||||
| 2026-03-31 | $2.70M 10-Q · filed 2026-05-11 | $5.38M derived: sum of 2 quarters · filed 2026-05-11 | $3.31M derived: sum of 3 quarters · filed 2026-05-11 | -$6.63M derived: sum of 4 quarters · filed 2026-08-17 | |||||
| 2025-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $605.97K derived: sum of 2 quarters · filed 2026-03-16 | -$9.33M derived: sum of 3 quarters · filed 2026-08-17 | -$17.64M 10-K · filed 2026-03-16 | |||||
| 2025-09-30 | -$2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$12.01M derived: sum of 2 quarters · filed 2026-08-17 | -$20.32M 10-Q · filed 2025-11-10 | -$27.27M derived: sum of 4 quarters · filed 2026-08-17 | |||||
| 2025-06-30 | -$9.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$18.25M 10-Q · filed 2026-08-17 | -$25.20M derived: sum of 3 quarters · filed 2026-08-17 | -$20.75M derived: sum of 4 quarters · filed 2026-08-17 | |||||
| 2025-03-31 | -$8.31M 10-Q · filed 2026-05-11 | -$7.68M 10-Q · filed 2025-05-08 | -$15.26M derived: sum of 2 quarters · filed 2026-05-11 | -$10.81M derived: sum of 3 quarters · filed 2026-05-11 | -$5.80M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$2.50M derived: sum of 2 quarters · filed 2026-03-16 | $2.51M derived: sum of 3 quarters · filed 2026-03-16 | $8.31M 10-K · filed 2026-03-16 | $8.56M 10-K · filed 2025-02-27 | ||||
| 2024-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $9.46M derived: sum of 2 quarters · filed 2025-11-10 | $15.26M 10-Q · filed 2025-11-10 | $15.33M 10-Q · filed 2024-11-07 | $25.85M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-06-30 | $5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.81M 10-Q · filed 2025-08-07 | $10.95M 10-Q · filed 2024-08-07 | $21.40M derived: sum of 3 quarters · filed 2026-03-16 | $23.66M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-03-31 | $5.80M 10-Q · filed 2025-05-08 | $16.39M derived: sum of 2 quarters · filed 2026-03-16 | $18.65M derived: sum of 3 quarters · filed 2026-03-16 | $6.33M derived: sum of 4 quarters · filed 2026-03-16 | |||||
| 2023-12-31 | $10.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $12.85M derived: sum of 2 quarters · filed 2026-03-16 | $530.10K derived: sum of 3 quarters · filed 2026-03-16 | -$2.05M 10-K · filed 2026-03-16 | -$1.78M 10-K · filed 2024-02-28 | ||||
| 2023-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$10.06M derived: sum of 2 quarters · filed 2024-11-07 | -$12.64M 10-Q · filed 2024-11-07 | -$5.02M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-06-30 | -$12.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$14.90M 10-Q · filed 2024-08-07 | -$7.28M derived: sum of 3 quarters · filed 2025-02-27 | -$8.34M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-03-31 | -$2.58M 10-Q · filed 2024-05-08 | $5.04M derived: sum of 2 quarters · filed 2025-02-27 | $3.98M derived: sum of 3 quarters · filed 2025-02-27 | $1.73M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2022-12-31 | $7.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.56M derived: sum of 2 quarters · filed 2025-02-27 | $4.31M derived: sum of 3 quarters · filed 2025-02-27 | $3.64M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$3.31M derived: sum of 2 quarters · filed 2023-11-06 | -$3.98M 10-Q · filed 2023-11-06 | -$1.53M derived: sum of 4 quarters · filed 2024-02-28 | |||||
| 2022-06-30 | -$2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.93M 10-Q · filed 2023-08-08 | -$470.27K derived: sum of 3 quarters · filed 2024-02-28 | $6.16M derived: sum of 4 quarters · filed 2024-02-28 | |||||
| 2022-03-31 | -$671.74K 10-Q · filed 2023-05-09 | $1.79M derived: sum of 2 quarters · filed 2024-02-28 | $8.42M derived: sum of 3 quarters · filed 2024-02-28 | $11.79M derived: sum of 4 quarters · filed 2024-02-28 | |||||
| 2021-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $9.09M derived: sum of 2 quarters · filed 2024-02-28 | $12.46M derived: sum of 3 quarters · filed 2024-02-28 | $11.88M 10-K · filed 2024-02-28 | |||||
| 2021-09-30 | $6.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $10.01M derived: sum of 2 quarters · filed 2022-11-08 | $9.42M 10-Q · filed 2022-11-08 | $149.41K 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.79M 10-Q · filed 2022-08-09 | $13.39K 10-Q · filed 2021-08-11 | ||||||
| 2021-03-31 | -$583.36K 10-Q · filed 2022-05-10 | $52.35K 10-Q · filed 2021-06-03 | |||||||
| 2020-12-31 | $11.66K 10-K/A · filed 2021-11-24 | $3.01M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |